Cerus Corp (CERS) Stock Price

CERSStock

$2.18+37.97%52W

Market Cap$439.32M

P/E—

PEG Ratio—

Div yield—

Beta1.86

CERS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-1.45%

Price vs S&P 500 (4W)-13.52%

VGM Score47.14

P/CF (Annual)90.83x

Book Value / Share (Quarterly)$0.35

P/TBV (Annual)11.14x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.48%

Cash Flow / Share (Quarterly)$-0.01

Price vs S&P 500 (YTD)-6.10%

Gross Margin (TTM)57.16%

Net Profit Margin (TTM)-2.73%

EPS (TTM)$-0.03

10-Day Avg Trading Volume1.84M

EPS Excl Extra (TTM)$-0.03

Revenue Growth (5Y)15.41%

EPS (Annual)$-0.08

ROI (Annual)-10.55%

Gross Margin (Annual)59.86%

Net Profit Margin (5Y Avg)-18.80%

Cash / Share (Quarterly)$0.28

Revenue Growth QoQ (YoY)5.28%

ROA (Last FY)-7.04%

Revenue Growth TTM (YoY)14.61%

EBITD / Share (TTM)$0.00

ROE (5Y Avg)-52.08%

Operating Margin (TTM)-0.65%

Cash Flow / Share (Annual)$0.01

P/B Ratio6.27x

P/B Ratio (Quarterly)8.36x

Net Income / Employee (Annual)$-56,800

EV / Revenue (TTM)1.96x

Net Interest Coverage (TTM)-0.59x

ROA (TTM)-3.14%

EV / EBITDA (TTM)7367.58x

EPS Incl Extra (Annual)$-0.08

Current Ratio (Annual)1.73x

Quick Ratio (Quarterly)1.02x

3-Month Avg Trading Volume2.33M

52-Week Price Return37.97%

EV / Free Cash Flow (Annual)438.86x

Revenue / Employee (TTM)$901,900

Tangible BV / Share (Quarterly)$0.62

P/S Ratio (Annual)1.88x

Asset Turnover (Annual)1.05x

52-Week High$3.47

Operating Margin (5Y Avg)-15.13%

EPS Excl Extra (Annual)$-0.08

CapEx CAGR (5Y)18.15%

Tangible BV CAGR (5Y)2.02%

26-Week Price Return8.46%

Quick Ratio (Annual)1.12x

13-Week Price Return-30.35%

Total Debt / Equity (Annual)1.31x

Current Ratio (Quarterly)1.83x

Enterprise Value$486.26M

Revenue / Share Growth (5Y)11.98%

Asset Turnover (TTM)1.15x

Book Value / Share Growth (5Y)-11.54%

Revenue / Employee (Annual)$850,200

Inventory Turnover (Annual)1.99x

Pretax Margin (Annual)-6.54%

Cash / Share (Annual)$0.43

3-Month Return Std Dev67.92%

Gross Margin (5Y Avg)60.54%

Net Income / Employee (TTM)$-24,700

ROE (Last FY)-24.33%

Net Interest Coverage (Annual)0.16x

EPS Basic Excl Extra (Annual)$-0.08

P/FCF (TTM)88.09x

Receivables Turnover (TTM)7.95x

EV / Free Cash Flow (TTM)512.50x

Total Debt / Equity (Quarterly)0.93x

EPS Incl Extra (TTM)$-0.03

Receivables Turnover (Annual)7.77x

ROI (TTM)-4.66%

P/S Ratio (TTM)1.77x

Pretax Margin (5Y Avg)-18.64%

Revenue / Share (Annual)$1.23

Tangible BV / Share (Annual)$0.62

Price vs S&P 500 (52W)22.44%

Year-to-Date Return5.83%

5-Day Price Return-3.54%

EPS Normalized (Annual)$-0.08

ROA (5Y Avg)-15.79%

Net Profit Margin (Annual)-6.68%

Month-to-Date Return-8.40%

Cash Flow / Share (TTM)$-0.26

EBITD / Share (Annual)$-0.04

Operating Margin (Annual)-3.71%

LT Debt / Equity (Annual)0.63x

P/CF (TTM)181.76x

ROI (5Y Avg)-24.05%

LT Debt / Equity (Quarterly)0.50x

EPS Basic Excl Extra (TTM)$-0.03

P/TBV (Quarterly)11.14x

P/B Ratio (Annual)6.16x

Inventory Turnover (TTM)1.77x

Pretax Margin (TTM)-2.60%

Book Value / Share (Annual)$0.33

Price vs S&P 500 (13W)-33.04%

Beta1.86x

P/FCF (Annual)396.50x

Revenue / Share (TTM)$1.24

ROE (TTM)-10.31%

52-Week Low$1.38

vGradeD

gGradeC

mGradeC

vgmGradeC

CERS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 30, 2026	-$0.01	-$0.01	+0.00%(+$0.00)
Q1 2026	Apr 30, 2026	-$0.04	-$0.01	+71.43%(+$0.03)
Q4 2025	Mar 2, 2026	-$0.01	-$0.01	-100.00%(-$0.01)
Q3 2025	Nov 6, 2025	-$0.03	$0.00	+100.00%(+$0.03)
Q2 2025	Aug 5, 2025	-$0.02	-$0.03	-50.00%(-$0.01)

CERS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.22

4.20

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Cerus Corp

Cerus Corp manufactures pathogen-reduction systems for blood transfusion safety, primarily through its INTERCEPT platelet and plasma products. The company operates globally across the United States, Europe, the Middle East, and select international markets. Blood safety represents its sole business focus and revenue driver.

CERS Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.01

Revenue estimate$61.10M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

CERS Insider Transactions

SellAug 17, 2026
JENSEN CHRYSTAL MENARD
Officer
Shares: 30,000Value: $89,529

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

CTKBCytek Biosciences, Inc. Common StockLab Analytical Instruments
AVRAnteris Technologies Global Corp. Common StockOrthopedic & Prosthetic Devices
PACBPacific Biosciences of California, Inc.Lab Analytical Instruments
MASS908 Devices Inc. Common StockLab Analytical Instruments
SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments
FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments
CVCapsoVision, Inc. Common StockElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Strong Buy

Consensus rating

52-Week Range

Low$1.38

High$3.47